NCT01669174View on ClinicalTrials.gov

BYM338 in Chronic Obstructive Pulmonary Disease (COPD) Patients With Cachexia

PHASE2CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Chronic Obstructive Pulmonary Disease (COPD) With Cachexia
Interventions
DRUG

Placebo

DRUG

BYM338

BYM338

Trial Locations (9)

6211

Novartis Investigative Site, Maastricht

29303

Novartis Investigative Site, Spartanburg

31419

Novartis Investigative Site, Savannah

59808

Novartis Investigative Site, Missoula

61761

Novartis Investigative Site, Normal

90502

Novartis Investigative Site, Torrance

LE1 5WW

Novartis Investigative Site, Leicester

SW 6NP

Novartis Investigative Site, London

M23 9QZ

Novartis Investigative Site, Machester

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY